v3.25.4
Intangible Assets
 6 Months Ended
Dec. 31, 2025
Intangible Assets [Abstract]  
INTANGIBLE ASSETS
4.INTANGIBLE ASSETS

 

The following table summarizes the Company’s intangible assets:

 

   December 31,
2025		   June 30,
2025		 
   $   $ 
         
Intellectual property   1,736,420    1,736,420 
Patents   1,191,000    1,191,000 
Intangible assets   2,927,420    2,927,420 
Less: accumulated amortization   (1,388,844)   (1,306,858)
Intangible assets, net   1,538,576    1,620,562 

 

Acquired intellectual property is recorded at cost and is amortized on a straight-line basis over 18 years. Acquired patents consist of patents related to the development of cannabinoid analogs. This intangible asset is being amortized over an estimated useful life of 18 years. As at December 31, 2025, the definite-lived intangible assets had a weighted average estimated remaining useful life of approximately 11 years. There was no impairment loss during the three and six months ended December 31, 2025 and 2024.

 

Amortization expense on intangible assets for the three months ended December 31, 2025 and 2024 was approximately $41,000 and $41,000 respectively. Amortization expense on intangible assets for the six months ended December 31, 2025 and 2024 was approximately $82,000 and $82,000 respectively. The Company expects amortization expense to be incurred over the next five years as follows:

  

Year ending June 30,  $ 
     
2026 (remaining)   81,373 
2027   162,746 
2028   162,746 
2029   162,746 
2030   162,746 
Thereafter   806,219 
Total   1,538,576